AUCTORES
Globalize your Research
Review Article | DOI: https://doi.org/DOI:10.31579/2693-2156/099
Research and Training Center ‘Physical and Chemical Materials Science’ Under Kyiv Taras Shevchenko University and NAS of Ukraine, Kiev, Ukraine
*Corresponding Author: P D Gupta, Former Director Grade Scientist, Centre for Cellular and Molecular Biology, Hyderabad, India.
Citation: P.D. Gupta, K Pushkala, (2024), Efficacy of Faecal Transplant Therapy in Non-alcoholic Fatty Liver Disease, J Thoracic Disease and Cardiothoracic Surgery, 5(5); DOI:10.31579/2693-2156/099
Copyright: © 2024, P D Gupta. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Received: 16 May 2024 | Accepted: 31 May 2024 | Published: 05 June 2024
Keywords: Non-alcoholic fatty liver; steatohepatitis; gut dysbiosis; rebiosis
Non-alcoholic fatty liver disease (NAFLD) is caused due to the tendency of the liver to build up fat in the liver causes Steatohepatitis. Unfortunately, in the present scenario, no specific treatment modality is available for a complete cure. The only way to manage this by lifestyle changes such as healthy diet, exercise, and weight management, but often difficult to guarantee for cure as well. Several human studies have legitimate evidence for the differences in the gut microbial population in patients with non-alcoholic steatohepatitis or non-alcoholic fatty liver disease. It is interesting to observe that even the characteristics of the gut microbiota between lean and obese patients varied in a wide range, and the patients in the two groups showed different responses to faecal transplant treatment. Faecal transplant therapy (FMT) could improve both lean and obese patients, but the treatment effect on lean patients was more promising than on obese patients. Taking advantage of FMT to prebiotic with beneficial bacteria could be a future challenge and success in therapeutics to cure non-alcoholic fatty liver disease.
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disease having a complex pathophysiology, yet to be well understood. This silent the disease has a tendency to build up fat in the liver which includes inflammation (NAFL) and with inflammation steatohepatitis (NASH). NASH resembles hepatitis caused by alcohol use, though it stems from something else. This disease is most often associated with being overweight, and having high blood lipids, and blood sugar. The global estimated prevalence of 25% in adults varies between countries, due to differences in age, gender, ethnicity, or dietary habits,including other reasons in patients who suffer from NAFLD. In addition to the accumulation of fat and liver damage, NAFLD is also responsible for obesity, metabolic syndrome, and type 2 diabetes [1]. NAFLD is a multi-systemic disease since it extends in the development of cirrhosis, or hepatocarcinoma, increased risk of cardiovascular disease, and extra hepatic cancer. Hepatic lipid accumulation from the absorption of circulating free fatty acids (FFAs), de novo lipogenesis, and dietary fats source leads to the development of NASH. Genetic factors, oxidative stress, mitochondrial dysfunction, pro-inflammatory factors, or gut-liver axis, and dysbiosis of the gut microbiome are also causative factors for NASH [2]. According to one estimate in 2030 non-alcoholic steatohepatitis (NASH) will increase by 15–56% [3].
Unfortunately, there is still no specific treatment available. Life style changes such as healthy diet, exercise, and weight loss, is the only therapeutic recommendation available right now, often difficult to guarantee as well [4-5].Considering the role of microbiota in the development and progression of NAFLD, alteration to intervene in the gut microbiota (GM) composition represents a possibility of promising treatment modality[2].
Possible relationship between microbiota and fatty liver diseases 100 trillion microorganisms (i.e., bacteria, viruses, parasites, and fungi) are estimated in the human gut, colonizing the gastrointestinal tract taking the responsibility of maintaining homeostasis. Specifically, 95% of these are Firmicutes (gram-positive), Bacteroidetes (gram-negative) and Actinobacteria (gram-positive) phyla. Disturbance of the balance between beneficial and pathogenic bacteria leads to a condition termed “dysbiosis” [6-7].
Several human studies have legitimate evidence for the differences in the gut microbial population in patients with non-alcoholic steatohepatitis (NASH) or non-alcoholic fatty liver disease (NAFLD), compared with healthy controls. Barrio et al., [2] have tabulated the studies done to confirm that dysbiosis observed in patients with NAFLD and non-alcoholic NASH. Furthermore, apart from increased endotoxemia, people with NAFLD have increased intestinal permeability, that correlates with bacterial overgrowth in the small intestine and the severity of steatosis. In addition, patients with NALFD have increased lipopolysaccharide (LPS) -binding peptide levels in the plasma, even higher in liver and correlate to TNF-α mRNA expression in liver tissue, pointing toward a role for endotoxemia in inflammatory liver steatosis since TNFα is a powerful pro-inflammatory agent [8].
Disruption of the intestinal epithelial and gut vascular barrier is proven as an early and prerequisite events in the development of NASH related to dysbiotic microbiota [9;10]. Mouries et al. [11] also suggested that not only bacterial products but also the bacteria themselves will be able to reach the liver, since bacteria in the liver parenchyma of mice fed with a high-fat diet (HFD) was identified. Possibly bacteria and their metabolites can also reach the liver, through the portal system, and induce an inflammatory response, liver injury and fibrosis [11]. Bauer [12] could colonize germ-free mice with stool microbes from 2-week-old infants born to obese mothers (Inf-ObMB) and showed an increase in histological signs of periportal inflammation, intestinal permeability and accelerated NAFLD progression when exposed to a Western-style diet [12].
FMT and Non-alcoholic fatty liver disease
FMT-dependent rebiotic in non-alcoholic fatty liver diseases ascertaining the efficiency in modulating gut microbiota to bring the gut microenvironment back to a healthy state is of great focus in the present scenario to escape from the side effects of the drug as well as the non-availability of treatment modality for a complete cure. A fresh fibre fiber-rich diet provides growth substances to microbes but processed food leads to the impairment of the gut barrier and an alteration of gut microbiota (GM). A high-salt diet is closely associated with a reduction of Lactobacillus abundance [13]. Exercise has an impact on the GM composition since it has been witnessed that in obese and overweight individuals, energy restriction, and a Mediterranean diet with physical activity reduced Firmicutes, especially Lachnospiraceae, after one year of intervention [14]. FMT is a treatment intended to restore a patient’s disturbed GM, by transferring minimally manipulated donor stool to the gut of the patient [2-15]. Limited studies indicated that microbiota-mediated effects on liver phenotype in mice model. In mice, antibiotics can reduce portal endotoxin levels and hepatic accumulation of lipids [16]. A human intervention trial, albeit not placebo-controlled, showed a decrease in intrahepatic triglyceride content measured by magnetic resonance spectroscopy upon the addition of probiotics to usual care [17].
Recently, however, the focus has been on the role of ethanoL-producing microbes in the etiology of NASH and NAFLD bridging between alcoholic and ‘non- alcoholic’ causes of steatohepatitis through the microbiome [18]. The use of antibiotics was suggested to have a long-term effect on the intestinal microbiota and its metabolites, at the expense of even affecting liver function through the “gut-liver” axis [19]. Antibiotic exposure may enhance the intestinal immune response and induce ROS accumulation and mitochondrial abnormalities in hepatocytes, thereby aggravating the adverse effects observed in HSD-fed mice [20].
Altering gut microbiota dysbiosis, by FMT was found effectively to improve the manifestations of NAFLD in animal models [5]. Therefore, human trials to apply FMT to treat patients with NAFLD in therapeutics has become an the attractive trend in the present situation similar to other nervous and non-nervous human diseases [21-30]. Xue, et al., [5] performed a randomized clinical trial to verify if the effects of faecal microbiota transfer from healthy donors can attenuate NAFLD and NASH severity. A total of 75 cases were recruited for the study, divided into the FMT group (n = 47), the non-FMT group (n = 28) and 10 healthy individuals as the control group. In the FMT group, 15 cases (31.9%) were lean and 32 cases (68.1%) were obese. Rebiosis with the help of FMT was able to decrease the fat accumulation in the liver in addition to significant differences in the clinical features of the disease and gut microbiota between lean and obese NAFLD patients. Moreover, FMT had better effects on gut microbiota reconstruction in lean NAFLD than in obese NAFLD patients [5]. Until now, only few human studies on the efficacy of FMT in the clinical treatment of NAFLD have been reported. The results of the randomized control trials have given a clue that FMT has the potential to reduce small intestinal permeability in patients with NAFLD [31]. Witjes et al. [32] also indicated that FMT from healthy donors could affect even hepatic gene expression and the plasma metabolites involved in inflammation and lipid metabolism suggesting the crosstalk between gut microbiota composition and NAFLD. Gut microbiota dysbiosis in patients with NAFLD was indicated by reducing bacterial diversity and decreasing beneficial bacteria resulting in metabolic disorders and opportunistic pathogen infection. Bacteroidetes, rumen bacteria, Christen senellaceae, and a few other bacteria were significantly reduced in patients with NAFLD. Bacteroidetes and rumen bacteria produce more butyric acid, which has the capability to protect the intestinal mucosal barrier [33] and enhance the body’s resistance to metabolic disorders caused by a high-fat diet are reduced [34]. Both Bacteroidetes and Muribaculaceae belong to the Bacteroidetes family, of which the Prior FMT group (pri FMT group) had a significantly lower proportion than the post-FMT group (po-FMT group) or the healthy group. There was no significant difference in certain bacterial contents between the po-FMT and healthy groups. Christensenellaceae member of the Firmicutes family is widely prevalent in the intestines and mucous membranes of humans as well as animals. In terms of genus, 14 genera of bacteria were significantly reduced in the intestinal tract of NAFLD patients, most of which are probiotics related to the maintenance of normal metabolism, immunity, and intact mucosal barrier. Christensenellaceae, was found to be significantly lower in the pri-FMT group compared to the po-FMT and healthy groups. Compared to the healthy group, the pri-FMT group had less proportions of the following 14 types of bacteria: Bacteroides, Christensenellaceae R
7, Metagenome, Ruminococcus 1, Tyzzerella 3, [Eubacterium] coprostanoligenes group, [Eubacterium] ruminantium group, Intestinimonas, Mitsuokella, Rikenellaceae RC9 gut group, Roseburia, and Subdoligranulum .
On the other hand, Escherichia–Shigella were more abundant in the pri-FMT group, but less in the po-FMT group. Surprisingly Escherichia–Shigella an opportunistic pathogen is closely related to systemic inflammatory response and impaired intestinal barrier was significantly increased [5]. A recent meta-analysis, which included 15 studies published from 2012 to 2020, showed that NAFLD patients had a greater abundance of SchEerichia, Prevotella and Streptococcus and less of Coprococcus, Faecalibacterium and Ruminococcus, but the significant heterogeneity limited the drawing of conclusions [35]. Xue, et al.[5] suggested that the difference in the gut microbiota which may be one of the main reasons for the differences between lean and obese NAFLD patients in their trial. The number of harmful bacteria involved in the pathogenesis of fatty liver and related to inflammatory reactions was increased more obviously in lean than in obese NAFLD patients, and the number of bacteria negatively correlated with body weight and blood glucose was also increased. It is suggested that the damage of the intestinal mucosal barrier in obese NAFLD patients can intensify the release of “harmful bacteria.”
It is interesting to observe that the characteristics of the gut microbiota between lean and obese patients with NAFLD varied in a wide range, and the patients in the two groups showed different responses to FMT. At the phylum level, the abundance of Actinobacteria in lean NAFLD patients
was significantly higher than that in obese NAFLD patients. At the order level, the abundance of Desulfovibrionales in lean NAFLD patients was significantly elevated than that in obese NAFLD patients. At the family level, the abundance of Tannerellaceae in lean NAFLD was increased compared to that in obese NAFLD patients. At the genus level, the abundance rates of Prevotella 2, Lachnospiraceae nk4a136 group, Lachnospiraceae nd3007 group, [Eubacterium] Coprostanoligenes, Mitsuokella, and Fusicatenibacter in lean NAFLD patients were significantly lower than those in obese NAFLD patients. At the species level, the abundances of Bacteroides copro cola DSM 17136 and uncultured Roseburia sp. in lean NAFLD were significantly higher than those in obese NAFLD patients, while Bifidobacterium longum subsp. longum was significantly higher in lean NAFLD than in obese NAFLD patients. Actinobacteria, Desulfovibrionales, Bacteroidaceae, Bacteroides, and [Ruminococcus] gnavus group were significantly decreased in the gut of lean NAFLD patients after FMT. On the other hand significant up regulation of Selenomonadales, Veillonellaceae, Prevotella 2,[Eubacterium] coprostanoligenes group, [Eubacterium] ruminantium group, human gut metagenome, and uncultured Roseburia sp. after FMT.
Xue, L et al., [5 ] pointed out in this study that the proportions of Prevotella 2, [Eubacterium] coprostanoligenes group, and [Eubacterium] ruminatum
the group before treatment was all 0%, which then significantly increased after FMT, while the proportion of [Ruminococcus] gnavus group before FMT was 2.9%, which then decreased to 0
FMT had beneficial effects on the improvement of lean than obese NAFLD patients. Lean and obese patients with NAFLD showed significant differences both in clinical manifestations and in the gut microbiota characteristics, mainly due to the different mechanisms of the gut microbiotadisorder. Prevalence of decreased gut microbiota numbers, butyrate-producing bacteria, and increased inflammation-inducing bacteria are responsible for the development of NAFLD. Taking advantage of FMT to rebiosis with beneficial bacteria could be a future challenge in therapeutics.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
